BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe ...

Millennium Laboratories launched a new highly sensitive and specific test to monitor patients using Butrans, a transdermal patch that delivers buprenorphine continuously for seven days. Butrans is ...

July 8, 2010 — The US Food and Drug Administration (FDA) has approved a once-weekly buprenorphine transdermal system (Butrans; Purdue Pharma LP) for the management of moderate to severe chronic pain ...

Transdermal buprenorphine may be an effective therapy for diabetic peripheral neuropathic pain (DPNP), however it was associated with a high rate of adverse events, mostly nausea and/or vomiting.

September 28, 2010 (Las Vegas, Nevada) — A transdermal application system containing the partial μ-opioid receptor agonist buprenorphine showed analgesic efficacy in the treatment of low back pain in ...

Purdue Pharma L.P. Receives FDA Approval for 7.5 mcg/hour Dosage Strength of Butrans® (Buprenorphine) Transdermal System CIII FDA also approves the use of two Butrans patches for dose adjustments in ...

GREENFIELD, Ind.--(BUSINESS WIRE)--With the U.S. Food and Drug Administration (FDA) approval of Zorbium™ (buprenorphine transdermal solution), Elanco Animal Health (NYSE: ELAN) expands its pain ...

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...

Key opportunities in the buprenorphine patch market include enhancing opioid stewardship, leveraging digital prescribing, securing robust supply chains, and aligning clinical protocols with payer and ...

At a PAINWeek 2012 presentation investigators reported that immediate-release opioids are acceptable to use as supplemental analgesia in certain situations, according to the Monthly Prescribing ...

FDA issues approval for new, prescription medication to control postoperative pain associated with surgical procedures in cats, expanding Elanco’s pain portfolio. A new long-acting medication to ...